Does Anesthesia, Invasive Surgery Increase Multiple Sclerosis Relapse Risk?

Hesitation to put MS patients on the operating table, due to relapse risk, may have physicians delaying important surgeries unnecessarily.

3:14 PM

Author | Jordyn Imhoff


A recent Multiple Sclerosis Journal study that included data from 281 patients and 609 surgeries suggests post-operative MS relapse risk does not significantly differ from pre-operative relapse risk.

No prior studies have systematically investigated the influence of surgery or anesthesia administration on relapse risk, but it's a large concern in clinical practice.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunes, Google Play and Stitcher.

This concern greatly impacts clinical decision making. These decisions, like neurology consultations for pre-operative clearance, can delay important surgeries, potentially unnecessarily.

Lindsey De Lott, M.D., assistant professor of neurology and first author of the manuscript, says she hopes this research gives physicians and patients the confidence in moving forward in the procedural decision making process.

"The idea that patients with MS might be at an increased risk of relapse following surgery isn't necessarily the case, so we need to be careful delaying important surgeries," says De Lott.

De Lott and senior author Tiffany Braley, M.D., M.S., associate professor of neurology and multiple sclerosis specialist, hypothesized that In the absence of post-operative complications, anesthesia exposure or surgery would not trigger functional decline or symptom recurrence.

Braley says the "vast majority" of her patients do well after surgery without evidence of relapse. So where do these concerns come from?

"In the rare instance when we have encountered a person with MS who developed neurological symptoms after surgery, the symptoms could usually be explained by a fever or infection," says Braley, "yet, the limited research previously done on this topic did not take these factors into account." 


Given these factors, patients who had surgical procedures that required minimal or no sedation, procedures expected to alter post-operative neurologic examinations, and procedures associated with immunosuppressive therapy use that may affect MS relapse rate (e.g. organ transplants) were excluded from the study.

The idea that patients with MS might be at an increased risk of relapse following surgery isn't necessarily the case, so we need to be careful delaying important surgeries.
Lindsey De Lott, M.D.

The investigators do point out that a MS relapse can manifest in many different ways, and there's always risk of over or underreporting when it comes to a patient's symptoms after a procedure.

"A relapse, or flare, can present as any neurologic symptom," says De Lott. "It can include weakness in an arm or leg, loss of sensation, vision loss, problems with walking or coordination … it spans the spectrum."

MORE FROM MICHIGAN: Sign up for our weekly newsletter

In this study, relapse was defined as lasting 24 hours or longer in the absence of a concurrent documented infection or fever. Both De Lott and Braley say it's not clear if it's the anesthesia or some other variable of surgery, like stress to the body, that could impact a person's relapse risk.

The investigators also point out that other factors such as age can affect relapse rate, and the study population included many older adults (mean age was 49-years-old, range 18-years old to 75-years old).  The few patients who did have post-operative relapses in the study (n=12) tended to be younger and had a higher frequency of enhancing lesions on a MRI, which Braley states may indicate more severe or active disease.

Additionally, only those procedures occurring at Michigan Medicine within a 90-day window were captured. Relapses outside that window could've been missed.

The crude estimate of the pre- and post-operative annualized relapse rates were 7.1 percent and 5.5 percent per patient per year, respectively. The odds of a post-operative relapse did not significantly differ from the odds of a pre-operative relapse even after adjusting for age and all other fixed between patient variables.

"Although a larger study is necessary to confirm our findings," Braley says, "these data suggest that surgery requiring anesthesia is not a trigger for MS relapse.  These results may allay concerns that many healthcare providers have when approaching MS patients for surgery."

Other study authors: Samantha Zerafa, research assistant at U-M's College of Engineering; Kerby Shedden, Ph.D., associate professor of Biostatistics at U-M's School of Public Health; Galit Levi Denietz, Ph.D., assistant professor in neurology; Michelle Earley, biostatistician II at George Washington University; and Benjamin Segal, M.D., professor of neurology.

More Articles About: Body Work Basic Science and Laboratory Research Multiple Sclerosis (MS) Anesthesiology and Anesthesia All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories pills floating blue pink dark background physician in middle looking at chart white coat scrubs
Health Lab
Better medical record-keeping needed to fight antibiotic overuse, studies suggest
Efforts to reduce overuse of antibiotics may be hampered by incomplete medical records that don’t show the full reasons for prescriptions.
surgery gloves passing tool blue and yellow
Health Lab
A universal heparin reversal drug is shown effective in mice
The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.
teal persons body looks like a puzzle red heart top right of shoulder and chest getting placed into missing piece spot
Health Lab
Normothermic perfusion system extends life of organs waiting for transplant
A team of researchers have spent the past eight years looking at better ways to transport organs for donation, specifically hearts, to improve the number of organs that can be used for transplants. They found that using a modified normothermic perfusion system heart preservation was feasible for up to 24 hours.
zoom screens with 7 different backgrounds and doctor silhouettes outlined in each
Health Lab
The doctor is in…. but what’s behind them?
A study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care.
blue gloves in hospital hanging IV bag
Health Lab
Commonly used antibiotic brings more complications, death in the sickest patients
In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.